The Use of Police Tactics To Disperse Protests and The Fine Line Between Legitimate Protesting and Anti-Social Behaviour

3PB’s pupil barrister Mariya Peykova has reviewed the use of police tactics to disperse protestors and the fine line between protesting and anti social behaviour.

View Publication

Duty of Care in the context of fatal RTAs: Valerie Tindall (2) Valerie Tindall (as administrator of the estate of Malcolm Tindall (deceased) v (1) Chief Constable of Thames Valley (2) Buckinghamshire County Council [2020] EWHC 837 (QB)

3PB's Grace Nicholls provides a case summary of Valerie Tindall (2) Valerie Tindall (as administrator of the estate of Malcolm Tindall (deceased) v (1) Chief Constable of Thames Valley (2) Buckinghamshire County Council [2020] EWHC 837 (QB).

View Publication

Secondary victims: what counts as ‘an event’?

3PB's Naomi Webber provides a case summary of Paul & Anor v Royal Wolverhampton NHS Trust [2020] EWHC 1415 (QB).

View Publication

Highways Act 1980 Case Summary & Comment: Deborah Barlow v Wigan Metropolitan Borough Council [2020 EWCA Civ 696]

3PB's Charles Fulton provides a case summary of Deborah Barlow v Wigan Metropolitan Borough Council [2020 EWCA Civ 696]

View Publication

The price of an unreasonable refusal to engage: ADR, Litigation and cost consequences

3PB’s specialist commercial law barristers David Parratt QC and Rebecca Farrell review the cost consequences for lawyers and their clients of a refusal to engage in ADR.

The article includes a recent case law review which demonstrates a particular trend whereby Courts will examine closely the actions of the parties in relation to offers of ADR as to whether they are ‘reasonable’ or not. Even the failure to respond to a Part 36 Offer alongside an offer to mediate, can of itself potentially signify an unreasonable refusal to engage with ADR.

View Publication

Novel foods regulation: Getting your product to the UK market

3PB’s Public and Regulatory Law barrister Matthew Wyard has reviewed the law regulating novel food products in the UK.

View Publication

UK Market Authorisation for New Medicinal Products

3PB’s Public and Regulatory barrister Matthew Wyard has provided an overview of the MHRA’s Market Authorisation process for bringing new products to market in the UK. Designed for the pharmaceutical industry and those advising them, this article looks at the different types of authorisation available and the process for approving medicines in the UK.

View Publication

Regulatory Update - The Tobacco Products Directive

3PB’s Public and Regulatory Law barrister Matthew Wyard has provided an update on UK tobacco law in light of Article 7 of the EU Tobacco Productive Directive.

View Publication